These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 30523734)
1. Increased serological, cancer-associated protein biomarker levels at diagnosis of large bowel adenoma: Risk of subsequent primary malignancy? Piper TB; Jørgensen LN; Olsen J; Nielsen KT; Davis G; Johansen JS; Jarle Christensen I; Nielsen HJ Acta Oncol; 2019; 58(sup1):S42-S48. PubMed ID: 30523734 [TBL] [Abstract][Full Text] [Related]
2. Serological cancer-associated protein biomarker levels at bowel endoscopy: Increased risk of subsequent primary malignancy. Piper TB; Nielsen HJ; Christensen IJ Tumour Biol; 2022; 44(1):1-16. PubMed ID: 35180141 [TBL] [Abstract][Full Text] [Related]
3. Increased serological cancer-associated biomarker levels at large bowel endoscopy and risk of subsequent primary cancer (†). Hvolris MH; Piper TB; Hammer E; Jørgensen LN; Olsen J; Rahr HB; Nielsen KT; Laurberg S; Christensen IJ; Brünner N; Johansen JS; Davis GJ; Dowell BL; Nielsen HJ Scand J Gastroenterol; 2016 Jul; 51(7):860-5. PubMed ID: 26918701 [TBL] [Abstract][Full Text] [Related]
4. Plasma TIMP-1 and CEA as Markers for Detection of Primary Colorectal Cancer: A Prospective Validation Study Including Symptomatic and Non-symptomatic Individuals. Christensen IJ; Brünner N; Dowell B; Davis G; Nielsen HJ; Newstead G; King D Anticancer Res; 2015 Sep; 35(9):4935-41. PubMed ID: 26254391 [TBL] [Abstract][Full Text] [Related]
5. Serum Cyr61 as a potential biomarker for diagnosis of colorectal cancer. Song YF; Xu ZB; Zhu XJ; Tao X; Liu JL; Gao FL; Wu CL; Song B; Lin Q Clin Transl Oncol; 2017 Apr; 19(4):519-524. PubMed ID: 27743169 [TBL] [Abstract][Full Text] [Related]
6. Serum YKL-40 in risk assessment for colorectal cancer: a prospective study of 4,496 subjects at risk of colorectal cancer. Johansen JS; Christensen IJ; Jørgensen LN; Olsen J; Rahr HB; Nielsen KT; Laurberg S; Brünner N; Nielsen HJ Cancer Epidemiol Biomarkers Prev; 2015 Mar; 24(3):621-6. PubMed ID: 25597749 [TBL] [Abstract][Full Text] [Related]
7. Plasma TIMP-1 and CEA in detection of primary colorectal cancer: a prospective, population based study of 4509 high-risk individuals. Nielsen HJ; Brünner N; Jorgensen LN; Olsen J; Rahr HB; Thygesen K; Hoyer U; Laurberg S; Stieber P; Blankenstein MA; Davis G; Dowell BL; Christensen IJ; ; Scand J Gastroenterol; 2011 Jan; 46(1):60-9. PubMed ID: 20799911 [TBL] [Abstract][Full Text] [Related]
8. Detection of colorectal neoplasia: Combination of eight blood-based, cancer-associated protein biomarkers. Wilhelmsen M; Christensen IJ; Rasmussen L; Jørgensen LN; Madsen MR; Vilandt J; Hillig T; Klaerke M; Nielsen KT; Laurberg S; Brünner N; Gawel S; Yang X; Davis G; Heijboer A; Martens F; Nielsen HJ Int J Cancer; 2017 Mar; 140(6):1436-1446. PubMed ID: 27935033 [TBL] [Abstract][Full Text] [Related]
9. Elevated serum YKL-40, IL-6, CRP, CEA, and CA19-9 combined as a prognostic biomarker panel after resection of colorectal liver metastases. Peltonen R; Gramkow MH; Dehlendorff C; Osterlund PJ; Johansen JS; Isoniemi H PLoS One; 2020; 15(8):e0236569. PubMed ID: 32756596 [TBL] [Abstract][Full Text] [Related]
10. Serum CEA and CA 19-9 Levels are Associated with the Presence and Severity of Colorectal Neoplasia. Kim NH; Lee MY; Park JH; Park DI; Sohn CI; Choi K; Jung YS Yonsei Med J; 2017 Sep; 58(5):918-924. PubMed ID: 28792134 [TBL] [Abstract][Full Text] [Related]
11. Should a colonoscopy be recommended for healthy individuals with increased carcinoembryonic antigen levels? A case-control study. Lee JH; Hong SP; Jeon TJ; Kang GH; Choi WC; Jeon SM; Moon CM; Park JJ; Cheon JH; Kim TI; Kim WH Dig Dis Sci; 2011 Aug; 56(8):2396-403. PubMed ID: 21327920 [TBL] [Abstract][Full Text] [Related]
12. [Prognostic value of carcinoembryonic antigen, alpha fetoprotein, carbohydrate antigen 125 and carbohydrate antigen 19-9 in gastroenteropancreatic neuroendocrine neoplasms]. Chen L; Zhang Y; Chen M; Chen J Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Sep; 20(9):1002-1008. PubMed ID: 28900990 [TBL] [Abstract][Full Text] [Related]
13. Matrix metalloproteinase 2 and tissue inhibitor of matrix metalloproteinases 2 in the diagnosis of colorectal adenoma and cancer patients. Groblewska M; Mroczko B; Gryko M; Kędra B; Szmitkowski M Folia Histochem Cytobiol; 2010 Dec; 48(4):564-71. PubMed ID: 21478099 [TBL] [Abstract][Full Text] [Related]
14. Serum angiogenin as a potential biomarker for early detection of colorectal adenomas and colorectal cancer. Yu D; Sun J; Weng Y; Luo L; Sheng J; Xu Z Anticancer Drugs; 2021 Aug; 32(7):703-708. PubMed ID: 33661188 [TBL] [Abstract][Full Text] [Related]
15. [Distribution characteristics and risk factors of colorectal adenomas]. Zhou H; Shen Z; Zhao J; Zhou Z; Xu Y Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Jun; 21(6):678-684. PubMed ID: 29968244 [TBL] [Abstract][Full Text] [Related]
16. Plasma Inflammatory Markers and Risk of Advanced Colorectal Adenoma in Women. Song M; Mehta RS; Wu K; Fuchs CS; Ogino S; Giovannucci EL; Chan AT Cancer Prev Res (Phila); 2016 Jan; 9(1):27-34. PubMed ID: 26511487 [TBL] [Abstract][Full Text] [Related]
17. Blood-based Biomarkers at Large Bowel Endoscopy and Prediction of Future Malignancies. Kring TS; Piper TB; Jørgensen LN; Olsen J; Rahr HB; Nielsen KT; Laurberg S; Davis G; Dowell B; Johansen JS; Christensen IJ; Brünner N; Nielsen HJ Biomark Cancer; 2015; 7():57-61. PubMed ID: 26526637 [TBL] [Abstract][Full Text] [Related]
18. Soluble E-cadherin as a serum biomarker candidate: elevated levels in patients with late-stage colorectal carcinoma and FAP. Weiss JV; Klein-Scory S; Kübler S; Reinacher-Schick A; Stricker I; Schmiegel W; Schwarte-Waldhoff I Int J Cancer; 2011 Mar; 128(6):1384-92. PubMed ID: 20473926 [TBL] [Abstract][Full Text] [Related]
19. Diagnostic value of carcinoembryonic antigen and carcinoma antigen 19-9 for colorectal carcinoma. Zhang SY; Lin M; Zhang HB Int J Clin Exp Pathol; 2015; 8(8):9404-9. PubMed ID: 26464695 [TBL] [Abstract][Full Text] [Related]
20. Can preoperative CEA and CA19-9 serum concentrations suggest metastatic disease in colorectal cancer patients? Stojkovic Lalosevic M; Stankovic S; Stojkovic M; Markovic V; Dimitrijevic I; Lalosevic J; Petrovic J; Brankovic M; Pavlovic Markovic A; Krivokapic Z Hell J Nucl Med; 2017; 20(1):41-45. PubMed ID: 28315907 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]